The ability of VEGFR1 activation to enhance perfusion even when eNOS-NO signaling is impaired demonstrates the translational potential of targeting VEGF165b to induce VEGFR1-mediated perfusion relief in PAD, where targeting VEGFR2/NO signaling has failed. This evidence concerns the gene NOS3 and peripheral arterial disease.